Joseph M. Pascuzzo, DO
NPI 1538244314ActiveIndividual· Internal Medicine, Hematology & Oncology· Fresno, CA
Internal Medicine, Hematology & Oncology (DO) in Fresno, California, trained at Philadelphia College of Osteopathic Medicine (class of 1981). In 2024 Medicare paid $4,665,194 for 951 patients, and Part D covered 1,567 of their prescriptions, 80% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 19 companies reporting payments in 2025, $969.03 in all, mostly food and beverage.
Overview
| NPI | 1538244314 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | DO |
| Sole proprietor | No |
| NPI issued | Oct 27, 2006 |
| Last updated in NPPES | Oct 9, 2025 |
| Certified by provider | Oct 9, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | 20A8935 | CA |
| Internal Medicine, Hospice and Palliative Medicine | 207RH0002X | 20A8935 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 951 |
|---|---|
| Services billed | 632,609 across 197 procedure codes |
| Paid by Medicare | $4,665,194 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,567 · 2,285 30-day fills |
|---|---|
| Patients | 322 |
| Total drug cost | $3,799,551 |
| Generic share | 80% of claims |
Education and affiliations
| Medical school | Philadelphia College of Osteopathic Medicine |
|---|---|
| Graduation year | 1981 |
| Medicare specialty | Medical Oncology |
| Secondary specialties | Internal Medicine |
Medical group
- California Cancer Associates for Research and Excellence IncSan Diego, CA · 65 clinicians
Industry payments (Open Payments)
- 2025$969.03 · 47 payments from 19 companies
- 2024$1,666 · 91 payments from 19 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $198.50 | 16 |
| Exelixis Inc. | $115.80 | 5 |
| Novartis Pharmaceuticals Corporation | $111.48 | 4 |
| Springworks Therapeutics, Inc. | $88.53 | 3 |
| Abbvie Inc. | $74.24 | 3 |
What the 2025 payments were for
- Food and Beverage$969.03 · 47 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other hematologist-oncologists in Fresno
- 1013032713
- 1144343005
- 1326087917
- 1326437468
- 1346398328
- 1407897093
- 1417904020
- 1417927054
- 1508024647
- 1659508281
- 1669466868
- 1699951582
All 37 hematologist-oncologists in Fresno · All hematologist-oncologists in California